CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-27 | Marshall Patrick Director | Grant or award | +19,000 | 71,666 | ||
| 2025-05-29 | Marshall Patrick Director | Grant or award | +11,000 | 52,666 | ||
| 2025-02-12 | Marshall Patrick Director | Grant or award | +41,666 | $1.92 | $80K | 41,666 |
| 2023-07-20 | Marshall Patrick Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 | ||
| 2023-07-20 | Marshall Patrick Director | Grant or award · Share Option (right to buy) | +20,000 | 20,000 |
Page 1 of 1 · 5 trades